Skip to main content

6-K

Ambev S.A. (ABEV)

6-K 2026-07-10 For: 2026-06-30
View Original
Added on July 10, 2026

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of July, 2026

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rdFloor04530-000 São Paulo, SPFederative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___ Form 40-F _______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes _______ No ___X____


INDIVIDUAL FORM

Article 11 - CVM Instruction # 44/2021

In June 2026:

(X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 44/2021.^(1)^

() no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 44/2021, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A. CPF/CNPJ: 07.526.557/0001-00
Qualification: Outstanding Shares in Treasury
Initial Balance
Securities / Derivatives Securities Characteristics ^(2)^ Quantity
Shares Common 247,967,585
ADR Common 0.00
Transactions in the month
Securities / Derivatives Securities Characteristics ^(2)^ Intermediary Operation Day Quantity Price Volume (R$)^(3)^
Shares Common Direct with Company Delivery of Restricted Shares 02 97,787 16.43 1,606,640.41
Shares Common Corretora Santander Purchase 01 3,000,000 16.4202 49,260,516.00
Shares Common Corretora Santander Purchase 02 3,000,000 16.5042 49,512,450.00
Shares Common Corretora Santander Purchase 03 3,000,000 16.1726 48,517,704.00
Shares Common Corretora Santander Purchase 05 3,000,000 16.1469 48,440,756.00
Shares Common Corretora Santander Purchase 08 3,000,000 16.0450 48,135,090.00
Shares Common Corretora Santander Purchase 09 3,000,000 16.2176 48,652,678.00
Shares Common Corretora Santander Purchase 10 3,000,000 16.2169 48,650,665.00
Shares Common Corretora Santander Purchase 11 3,000,000 16.4623 49,387,015.00
Shares Common Corretora Santander Purchase 12 3,000,000 16.6026 49,807,830.00
Shares Common Corretora Santander Purchase 15 3,000,000 16.6607 49,982,016.00
Shares Common Corretora Santander Purchase 16 3,000,000 16.4201 49,260,343.00
Shares Common Corretora Santander Purchase 17 3,000,000 16.4908 49,472,417.00
Shares Common Corretora Santander Purchase 18 3,000,000 16.2220 48,665,940.00
Shares Common Corretora Santander Purchase 19 3,000,000 16.2255 48,676,603.00
Shares Common Corretora Santander Purchase 22 3,000,000 16.2464 48,739,314.00
Shares Common Corretora Santander Purchase 23 3,000,000 16.3358 49,007,467.00
Shares Common Corretora Santander Purchase 24 3,000,000 16.4288 49,286,523.00
Shares Common Corretora Santander Purchase 25 3,000,000 16.3753 49,125,810.00
Shares Common Corretora Santander Purchase 26 3,000,000 16.6464 49,939,091.00
Shares Common Corretora Santander Purchase 29 3,000,000 16.6634 49,990,176.00
Shares Common Corretora Santander Purchase 30 3,000,000 16.3218 48,965,448.00
Final Balance
Securities / Derivatives Securities Characteristics ^(2)^ Quantity
Shares Common 310,869,798
ADR Common 0

(1) When filling in the form, delete the lines thatdo not have any information, If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction# 44/2021, send a statement with that information,

**(2)**Issue/Series, convertibility, simple, term, guaranties, type/class, among others,

(3) Quantity multiplied by price,

(*) Each ADR is equivalent to 1 (one) share,

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: July 8, 2026

AMBEV S.A.
By: /s/ Guilherme Fleury de Figueiredo Ferraz Parolari
Guilherme Fleury de Figueiredo Ferraz Parolari<br><br> <br>Chief Financial and Investor Relations Officer